Filing Details
- Accession Number:
- 0001181431-10-059236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-03 12:00:00
- Reporting Period:
- 2010-12-02
- Filing Date:
- 2010-12-03
- Accepted Time:
- 2010-12-03 16:02:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1162059 | C Russell Hirsch | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-12-02 | 317,572 | $14.93 | 1,270,142 | No | 4 | S | Indirect | By Prospect Venture Partners II, L.P. |
Common Stock | Disposition | 2010-12-02 | 4,836 | $14.93 | 19,341 | No | 4 | S | Indirect | By Prospect Associates II, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Prospect Venture Partners II, L.P. |
No | 4 | S | Indirect | By Prospect Associates II, L.P. |
Footnotes
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.50 to $15.00, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- Held by Prospect Venture Partners II, L.P. Alexander E. Barkas, Ph.D., David Schnell, M.D. and Russell C. Hirsch, M.D., Ph.D., the managing members of Prospect Management Co. II, LLC, the General Partner of Prospect Venture Partners II, L.P., share voting and investment power over the shares held by Prospect Venture Partners II, L.P., but disclaim beneficial ownership, except to the extent of their pecuniary interest therein.
- Held by Prospect Associates II, L.P. Alexander E. Barkas, Ph.D., David Schnell, M.D. and Russell C. Hirsch, M.D., Ph.D., the managing members of Prospect Management Co. II, LLC, the General Partner of Prospect Associates II, L.P., share voting and investment power over the shares held by Prospect Associates II, L.P., but disclaim beneficial ownership, except to the extent of their pecuniary interest therein.